EDESA BIOTECH, INC. Increase (Decrease) in Deferred Charges
EDESA BIOTECH, INC. (EDSA) reported Increase (Decrease) in Deferred Charges of $0 for the 9-month period ending 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2017-08-09
- EDESA BIOTECH, INC. increase (decrease) in deferred charges for the quarter ending 2016-09-30 was -$232.82K.
- EDESA BIOTECH, INC. increase (decrease) in deferred charges for the quarter ending 2015-09-30 was $0.00.
- EDESA BIOTECH, INC. increase (decrease) in deferred charges for fiscal 2016 was $0.00.
- EDESA BIOTECH, INC. increase (decrease) in deferred charges for fiscal 2015 was $0.00.
- EDESA BIOTECH, INC. increase (decrease) in deferred charges for fiscal 2014 was -$60.66K, a 197.79% decline from fiscal 2013.
- EDESA BIOTECH, INC. increase (decrease) in deferred charges for fiscal 2013 was $62.03K.
| Period end | Increase (Decrease) in Deferred Charges 1 month | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | |||
| 2016-09-30 | -$232.82K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $0.00 10-K · filed 2016-12-14 | ||
| 2016-06-30 | $232.82K 10-Q · filed 2017-08-09 | |||
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $0.00 10-K · filed 2016-12-14 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | |||
| 2014-09-30 | $0.00 10-K · filed 2016-12-14 | |||
| 2014-08-31 | -$60.66K 10-K · filed 2016-12-14 | |||
| 2013-08-31 | $62.03K 10-K · filed 2015-12-14 | |||
| 2012-08-31 | $0.00 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |